Browse the corpus

This activity aligns with the American Board of Obesity Medicine's content blueprint for the Obesity Medicine board exam. Specifically, this course covers the material in the "A" duties of a physician (A: Evaluating, Examining, and Diagnosing) and the necessary tasks 9 and 10 in the outline (ie, A: 9 and 10 in the exam blueprint): history and diagnosis of weight-related metabolic and biomechanical complications. Obesity is a chronic disease associated with a broad spectrum of metabolic, biomechanical, and psychosocial complications that emerge across the lifespan. Excess adiposity contributes to the development of cardiometabolic conditions, including insulin resistance, dyslipidemia, hypertension, and type 2 diabetes, while impairing pulmonary, musculoskeletal, gastrointestinal, reproductive, and neurological health. Obstructive sleep apnea, metabolic dysfunction–associated steatotic liver disease (MASLD), polycystic ovary syndrome, slipped capital femoral epiphysis, and pubertal abnormalities represent important obesity-related conditions requiring early recognition. The complex, multisystem impact of obesity highlights the need for age-specific diagnostic criteria and integrated approaches to evaluation, particularly for pediatric populations in whom comorbidities may present differently. Failure to implement systematic, comprehensive screening strategies often results in delayed diagnoses, preventable complications, and suboptimal long-term outcomes. This course equips clinicians with evidence-based strategies for conducting comprehensive histories, performing targeted examinations, and implementing systematic, age-appropriate screening protocols to identify obesity-related comorbidities in both adult and pediatric populations. Participants learn to recognize early clinical indicators of metabolic and biomechanical complications, utilize validated tools, and apply current diagnostic classifications such as MASLD. Emphasis is placed on interprofessional collaboration, as clinicians, dietitians, mental health professionals, and other healthcare team members align their approaches to ensure timely, coordinated, patient-centered care. Objectives: Identify the multisystem pathophysiologic mechanisms that link obesity to metabolic, cardiovascular, pulmonary, musculoskeletal, gastrointestinal, reproductive, and neurological complications.

This course equips clinicians with evidence-based strategies for conducting comprehensive histories, performing targeted examinations, and implementing systematic, age-appropriate screening protocols to identify obesity-related comorbidities in both adult and pediatric populations. Participants learn to recognize early clinical indicators of metabolic and biomechanical complications, utilize validated tools, and apply current diagnostic classifications such as MASLD. Emphasis is placed on interprofessional collaboration, as clinicians, dietitians, mental health professionals, and other healthcare team members align their approaches to ensure timely, coordinated, patient-centered care. Objectives: Identify the multisystem pathophysiologic mechanisms that link obesity to metabolic, cardiovascular, pulmonary, musculoskeletal, gastrointestinal, reproductive, and neurological complications. Evaluate obesity complications, including reproductive, gynecologic, and pubertal disorders, such as polycystic ovary syndrome, using appropriate criteria and Tanner staging assessment for pubertal development. Screen patients using appropriate protocols to detect obesity-associated disorders early. Collaborate effectively across the interprofessional healthcare team, including physicians, advanced practitioners, nurses, dietitians, physical therapists, and other allied health professionals, to ensure comprehensive assessment, accurate diagnosis, and coordinated management of obesity-related metabolic and biomechanical complications, thereby optimizing patient outcomes. Access free multiple choice questions on this topic.

Obesity has reached epidemic proportions globally, affecting over 650 million adults and 340 million children and adolescents worldwide.[1] In the United States, approximately 36% of adults and 17% of children are classified as obese, with rates continuing to rise across all demographic groups.[2] The clinical significance of obesity extends far beyond its impact on body weight, as this condition serves as a key pathophysiologic driver of numerous metabolic, cardiovascular, pulmonary, musculoskeletal, and reproductive complications. The relationship between obesity and its associated complications is complex and bidirectional. Obesity is a key pathophysiologic driver of diabetes, other cardiovascular risk factors (eg, hypertension, hyperlipidemia, metabolic dysfunction-associated steatotic liver disease, and an inflammatory state), and ultimately cardiovascular and kidney disease.[2] Understanding these relationships is crucial for healthcare professionals, as early identification and intervention can significantly improve patient outcomes and reduce the burden of chronic disease. The systematic evaluation of obesity-related complications necessitates a comprehensive understanding of the mechanisms underlying these conditions and the age-specific manifestations that occur across the lifespan. This approach enables healthcare practitioners to implement targeted screening protocols, recognize early warning signs, and provide appropriate interventions or referrals to prevent progression of complications. Pause and Reflect. Table A 45-year-old individual with a body mass index (BMI) of 42 kg/m² presents for a comprehensive obesity evaluation. They report no specific symptoms but are concerned about their health. Which systems would you prioritize in your assessment, and (more...)

The comprehensive evaluation of weight-related complications in patients with obesity requires age-specific, evidence-based strategies to identify and manage metabolic and cardiovascular risks. In children, obesity significantly increases the likelihood of hypertension, insulin resistance, and dyslipidemia, necessitating early, targeted screening and coordinated care to prevent lifelong complications. Adults with obesity also face elevated risks for metabolic syndrome, type 2 diabetes, dyslipidemia, and cardiovascular disease, underscoring the need for regular assessment and intervention. Physicians, advanced practitioners, nurses, pharmacists, and other healthcare professionals play vital roles in recognizing obesity-related complications and initiating appropriate management. Clinicians must be proficient in assessing BMI percentiles in children, interpreting HbA1c and lipid profiles, and identifying signs of insulin resistance, such as acanthosis nigricans. Screening should follow established guidelines, with universal lipid and glucose monitoring at key developmental stages in children and tailored assessments for adults based on risk factors. Understanding underlying pathophysiologic mechanisms, including sympathetic nervous system activation and vascular dysfunction, supports timely diagnosis and treatment of obesity-related hypertension and metabolic disturbances. Interprofessional communication and coordination enhance the effectiveness of care by ensuring consistency across assessments, education, treatment plans, and follow-up. Nurses and pharmacists contribute to patient education and medication safety, while physicians and advanced practitioners lead comprehensive evaluation and management. Collaborative, patient-centered approaches enable early intervention, reduce long-term complications, and support evidence-based care that is developmentally appropriate for both pediatric and adult patients with obesity.